NCT05166850 Preventative Intervention for Cholera for 7 Days
| NCT ID | NCT05166850 |
| Status | Recruiting |
| Phase | — |
| Sponsor | Johns Hopkins Bloomberg School of Public Health |
| Condition | Cholera |
| Study Type | INTERVENTIONAL |
| Enrollment | 2,900 participants |
| Start Date | 2021-12-22 |
| Primary Completion | 2026-12-22 |
Eligibility & Interventions
Eligibility Fast-Check
Enter your details for a quick preliminary check. This does not replace medical advice.
What to Expect as a Participant
You will actively receive the study intervention — which may be a drug, biologic, device, or procedure.
This trial targets 2,900 participants in total. It began in 2021-12-22 with a primary completion date of 2026-12-22.
⚠ This information is for research awareness only. Always consult your physician before joining any clinical trial. Participation is voluntary and you may withdraw at any time.
Brief Summary
The first objective of our study is to develop a theory-driven evidence-based targeted water, sanitation, and hygiene (WASH) intervention for household members of diarrhea patients in South Kivu, Democratic Republic of the Congo (DRC) through formative research and community engagement. The second objective is to conduct a randomized controlled trial of 2,320 household members of 580 severe diarrhea patients to evaluate the effectiveness of the developed targeted WASH intervention in terms of: 1. reducing diarrheal diseases household members of cholera and severe diarrhea patients; and 2. increasing WASH behaviors.
Eligibility Criteria
Inclusion Criteria: * Diarrhea patients presenting with three or more loose stools over a 24h period * Having no running water inside of their home * Plan to reside in Bukavu for the next 12 months * Have a child \<5 years in their household * Have a working mobile phone in the household Exclusion Criteria: * No one will be excluded because of age, sex, religion, or sexual preference * Presenting at the health facility with a fever (COVID-19 prevention)
Contact & Investigator
Christine Marie George, PhD
PRINCIPAL INVESTIGATOR
Associate Professor
Frequently Asked Questions
Who can join the NCT05166850 clinical trial?
This trial is open to participants of all sexes, studying Cholera. Full inclusion and exclusion criteria are listed in the Eligibility Criteria section. Always confirm your eligibility with the research team before applying.
Is NCT05166850 currently recruiting?
Yes, NCT05166850 is actively recruiting participants. Contact the research team at cmgeorge@jhu.edu for enrollment information.
Where is the NCT05166850 trial being conducted?
This trial is being conducted at Bukavu, Democratic Republic of the Congo, Bukavu, Democratic Republic of the Congo.
Who is sponsoring the NCT05166850 clinical trial?
NCT05166850 is sponsored by Johns Hopkins Bloomberg School of Public Health. The principal investigator is Christine Marie George, PhD at Associate Professor. The trial plans to enroll 2,900 participants.